Talaris Therapeutics Inc

NASDAQ:TALS   3:59:52 PM EDT
13.54
+1.16 (+9.37%)
Earnings Announcements

Talaris Therapeutics Announces Third Quarter 2021 Financial Results And Provides Business Update

Published: 11/12/2021 12:41 GMT
Talaris Therapeutics Inc (TALS) - Talaris Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update.
Q3 Loss per Share $0.32.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.38

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.47

More details on our Analysts Page.